pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
sacituzumab tirumotecan · news · pharmadog
← back to sacituzumab tirumotecan
News mentioning sacituzumab tirumotecan
20
stories
7h
Merck-Kelun ADC scores survival win in Phase 3 gastroesophageal cancer trial
biospace
7h
Merck-Kelun ADC scores survival win in Phase 3 stomach cancer trial
biospace
14h
Merck’s TROP2 ADC extends survival in pivotal gastroesophageal cancer trial
fiercebiotech
8d
Pfizer taps Blackstone for up to $1.5B to pave path to GLP-1's obesity launch
fiercebiotech
16d
6 potential blockbusters that could pave China’s path to 2030 ambitions
biospace
22d
Merck looks ahead to ‘another year of investment’ as Keytruda cliff looms
biospace
24d
From RAS rivalries to leaked cancer vaccine readouts, ESMO brought the data drama
fiercebiotech
25d
ESMO 2026: Merck’s Kelun-partnered ADC cuts death risk by over 30% in endometrial cancer
biospace
25d
STAT+: Merck ADC drug cut risk of death by one-third in advanced endometrial cancer
stat
29d
ESMO 2026: Merck’s Kelun-partnered ADC hits the ‘Goldilocks zone,’ VP says
biospace
Oct 19, 26
Merck/Moderna, Summit/Akeso and ADCs to headline ESMO 2026
biospace
Sep 28, 26
Merck, Daiichi Sankyo retract accelerated approval request for lung cancer ADC
biospace
Sep 24, 26
Merck’s experimental eye drug matches Roche’s VEGF inhibitor but safety concerns emerge
biospace
Jul 27, 26
Summit, Merck must navigate new regulatory terrain in China-first cancer landscape
biospace
Jul 16, 26
Kelun pads efficacy profile of Merck-partnered ADC; Europe will have to wait for Boehringer's Hernexeos
endpoints
Jul 15, 26
Kelun’s Merck-partnered ADC notches late-stage NSCLC win alongside Keytruda
biospace
Jun 9, 26
Merck, Gilead report mixed outcomes in key lung cancer, HIV studies
biopharma dive
May 29, 26
At ASCO, Merck makes case for a ‘cornerstone’ cancer drug
biopharma dive
May 18, 26
Merck ADC, licensed from China, hits mark in first big global trial
biopharma dive
May 7, 26
Track the Lung Cancer Abstracts That are Gaining Attention at ASCO 2026
onclive